Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B386
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 1 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006950 | response to stress | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010033 | response to organic substance | 3 | 1 |
GO:0010243 | response to organonitrogen compound | 4 | 1 |
GO:0010498 | proteasomal protein catabolic process | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 1 |
GO:0030163 | protein catabolic process | 4 | 1 |
GO:0030433 | ubiquitin-dependent ERAD pathway | 6 | 1 |
GO:0033554 | cellular response to stress | 3 | 1 |
GO:0034976 | response to endoplasmic reticulum stress | 4 | 1 |
GO:0036503 | ERAD pathway | 5 | 1 |
GO:0042221 | response to chemical | 2 | 1 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 1 |
GO:0051716 | cellular response to stimulus | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1901698 | response to nitrogen compound | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0051087 | protein-folding chaperone binding | 3 | 1 |
GO:0051787 | misfolded protein binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 127 | 129 | PF00675 | 0.553 |
CLV_NRD_NRD_1 | 134 | 136 | PF00675 | 0.438 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.640 |
CLV_PCSK_KEX2_1 | 127 | 129 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.673 |
CLV_PCSK_PC1ET2_1 | 133 | 135 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.384 |
DOC_PP1_RVXF_1 | 52 | 59 | PF00149 | 0.274 |
DOC_USP7_MATH_1 | 169 | 173 | PF00917 | 0.699 |
DOC_USP7_MATH_1 | 208 | 212 | PF00917 | 0.561 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.479 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.350 |
DOC_WW_Pin1_4 | 96 | 101 | PF00397 | 0.587 |
LIG_14-3-3_CanoR_1 | 10 | 19 | PF00244 | 0.564 |
LIG_14-3-3_CanoR_1 | 118 | 126 | PF00244 | 0.533 |
LIG_14-3-3_CanoR_1 | 186 | 192 | PF00244 | 0.478 |
LIG_14-3-3_CanoR_1 | 23 | 30 | PF00244 | 0.368 |
LIG_14-3-3_CanoR_1 | 264 | 274 | PF00244 | 0.561 |
LIG_APCC_ABBA_1 | 103 | 108 | PF00400 | 0.546 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.617 |
LIG_BIR_III_4 | 320 | 324 | PF00653 | 0.443 |
LIG_BRCT_BRCA1_1 | 49 | 53 | PF00533 | 0.350 |
LIG_CtBP_PxDLS_1 | 100 | 104 | PF00389 | 0.491 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.505 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.534 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.643 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.671 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.475 |
LIG_FHA_2 | 24 | 30 | PF00498 | 0.295 |
LIG_FHA_2 | 299 | 305 | PF00498 | 0.608 |
LIG_LIR_Apic_2 | 201 | 207 | PF02991 | 0.593 |
LIG_LIR_Gen_1 | 13 | 21 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 298 | 303 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 298 | 302 | PF02991 | 0.458 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.315 |
LIG_LYPXL_SIV_4 | 169 | 177 | PF13949 | 0.445 |
LIG_PTB_Apo_2 | 139 | 146 | PF02174 | 0.436 |
LIG_SH2_CRK | 204 | 208 | PF00017 | 0.671 |
LIG_SH2_CRK | 297 | 301 | PF00017 | 0.460 |
LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.476 |
LIG_SH2_STAP1 | 283 | 287 | PF00017 | 0.486 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.453 |
LIG_WRC_WIRS_1 | 299 | 304 | PF05994 | 0.538 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.675 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.655 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.627 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.483 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.505 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.315 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.702 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.483 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.364 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.512 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.662 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.641 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.535 |
MOD_GlcNHglycan | 241 | 245 | PF01048 | 0.776 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.698 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.581 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.634 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.503 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.684 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.424 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.616 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.588 |
MOD_N-GLC_1 | 23 | 28 | PF02516 | 0.423 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.748 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.368 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.617 |
MOD_NEK2_1 | 248 | 253 | PF00069 | 0.573 |
MOD_NEK2_1 | 266 | 271 | PF00069 | 0.473 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.533 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.588 |
MOD_PIKK_1 | 110 | 116 | PF00454 | 0.503 |
MOD_PIKK_1 | 23 | 29 | PF00454 | 0.417 |
MOD_PK_1 | 215 | 221 | PF00069 | 0.456 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.526 |
MOD_PKA_2 | 9 | 15 | PF00069 | 0.553 |
MOD_Plk_1 | 2 | 8 | PF00069 | 0.589 |
MOD_Plk_2-3 | 298 | 304 | PF00069 | 0.502 |
MOD_Plk_4 | 2 | 8 | PF00069 | 0.637 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.506 |
MOD_ProDKin_1 | 96 | 102 | PF00069 | 0.586 |
MOD_SUMO_for_1 | 145 | 148 | PF00179 | 0.476 |
MOD_SUMO_rev_2 | 137 | 143 | PF00179 | 0.501 |
MOD_SUMO_rev_2 | 80 | 85 | PF00179 | 0.467 |
TRG_DiLeu_BaEn_4 | 198 | 204 | PF01217 | 0.565 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.314 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.274 |
TRG_ER_diArg_1 | 126 | 128 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 153 | 156 | PF00400 | 0.583 |
TRG_ER_diArg_1 | 261 | 264 | PF00400 | 0.713 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.489 |
TRG_Pf-PMV_PEXEL_1 | 28 | 32 | PF00026 | 0.417 |
TRG_Pf-PMV_PEXEL_1 | 69 | 73 | PF00026 | 0.334 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IML6 | Leptomonas seymouri | 55% | 100% |
A0A0S4ILI1 | Bodo saltans | 35% | 100% |
A0A1X0NRT2 | Trypanosomatidae | 45% | 100% |
A0A3Q8IHA8 | Leishmania donovani | 87% | 100% |
A0A422NYS2 | Trypanosoma rangeli | 42% | 100% |
A4HKU8 | Leishmania braziliensis | 78% | 100% |
A4I8C7 | Leishmania infantum | 87% | 100% |
D0AAU5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
Q4Q4W9 | Leishmania major | 87% | 100% |
V5BL40 | Trypanosoma cruzi | 44% | 100% |